Trial intelligence / Profile preview

One-day rTMS + D-cycloserine to Treat PTSD in Military Personnel and Veterans

NCT07777380Phase 2Not yet recruiting

Start
Nov 2026
Primary completion
Jun 2028
Countries
1
01

Overview

A Phase 2 trial of d-cycloserine in post-traumatic stress disorder (PTSD). Planned start Nov 2026; status: not yet recruiting.

02

Drugs

d-cycloserine
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT07777380.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07777380.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call